Jazz Pharmaceuticals (JAZZ) Prices IPO Between $24-26 Per Share

Article Stock Quotes (1) Comments (0)

Jazz Pharmaceuticals, Inc (Nasdaq: JAZZ) has filed an amended S-1 statement with the SEC. The Company now expects the public offering price to be between $24.00-26.00 per share. The Company is offering 6.0 million shares. The company plans to list on the Nasdaq Global Market under the symbol "JAZZ".

The offering is being made through Credit Suisse, Morgan Stanley, Lehman Bros. and Natexis Bleichroeder.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

You May Also Be Interested In

• Elon Musk Says SpaceX Won't IPO Until Mars is a Reality
• Russia's Lenta Said to Select Bankers for Massive IPO - Reuters
• Envision Healthcare (EVH) Files $100M IPO

Create E-mail Alert Related Categories

IPOs

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?